Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
GTE
|
Gmt Capital Corp
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 1,488,120 Reduced 2.53% |
$907,753
$0.61 p/Share
|
Jan 29
2021 |
NOW
|
William R Mc Dermott
Chairman & CEO |
SELL
Open market or private sale
|
Direct | 7,183 Reduced 100.0% |
$3,921,415
$545.93 p/Share
|
Jan 29
2021 |
NOW
|
William R Mc Dermott
Chairman & CEO |
SELL
Open market or private sale
|
Direct | 37,627 Reduced 83.97% |
$20,241,822
$537.96 p/Share
|
Jan 29
2021 |
NOW
|
Gina Mastantuono
President and CFO |
SELL
Open market or private sale
|
Direct | 3,798 Reduced 100.0% |
$2,080,089
$547.68 p/Share
|
Jan 29
2021 |
NOW
|
Paul Edward Chamberlain
Director |
SELL
Open market or private sale
|
Direct | 75 Reduced 0.78% |
$41,181
$549.08 p/Share
|
Jan 29
2021 |
XEL
|
Frank P Prager
SVP, Strategy and External Aff |
SELL
Open market or private sale
|
Direct | 3,711 Reduced 9.98% |
$235,463
$63.45 p/Share
|
Jan 29
2021 |
DLR
|
Cindy Fiedelman
CHIEF HUMAN RESOURCES OFFICER |
SELL
Open market or private sale
|
Direct | 1,024 Reduced 100.0% |
$147,282
$143.83 p/Share
|
Jan 29
2021 |
IBKR
|
Thomas Peterffy
Chairman |
SELL
Open market or private sale
|
Direct | 14,400 Reduced 0.16% |
$880,704
$61.16 p/Share
|
Jan 29
2021 |
BGNE
|
Jane Huang
CMO, Hematology |
SELL
Open market or private sale
|
Direct | 1,500 Reduced 100.0% |
$486,255
$324.17 p/Share
|
Jan 29
2021 |
TER
|
Charles Jeffrey Gray
VP, General Counsel, Secretary |
SELL
Open market or private sale
|
Direct | 18,941 Reduced 37.35% |
$2,237,500
$118.13 p/Share
|
Jan 29
2021 |
WDC
|
Michael Charles Ray
EVP, Chief Legal Officer & Sec |
SELL
Open market or private sale
|
Direct | 22,735 Reduced 27.0% |
$1,362,281
$59.92 p/Share
|
Jan 29
2021 |
CZR
|
Anthony L. Carano
President and COO |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 25.95% |
$1,781,750
$71.27 p/Share
|
Jan 29
2021 |
CZR
|
Thomas Reeg
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 70,000 Reduced 24.94% |
$4,987,500
$71.25 p/Share
|
Jan 29
2021 |
OSK
|
Wilson R Jones
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 21,926 Reduced 11.57% |
$2,047,011
$93.36 p/Share
|
Jan 29
2021 |
ENSG
|
Daren Shaw
Director |
SELL
Open market or private sale
|
Direct | 625 Reduced 1.45% |
$50,500
$80.8 p/Share
|
Jan 29
2021 |
CVNA
|
Ernest C. Garcia Ii |
SELL
Open market or private sale
|
Direct | 15,269 Reduced 100.0% |
$3,995,287
$261.66 p/Share
|
Jan 29
2021 |
CVNA
|
Ernest C. Garcia Ii |
SELL
Open market or private sale
|
Direct | 34,731 Reduced 100.0% |
$8,771,314
$252.55 p/Share
|
Jan 29
2021 |
AMED
|
Scott G Ginn
EVP, CFO & COO |
SELL
Open market or private sale
|
Direct | 975 Reduced 5.18% |
$279,698
$286.87 p/Share
|
Jan 29
2021 |
QTWO
|
Matthew P Flake
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 3.57% |
$1,296,700
$129.67 p/Share
|
Jan 29
2021 |
EXPI
|
Penny Sanford |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 0.14% |
$2,160,600
$108.03 p/Share
|
Jan 29
2021 |
AAWW
|
Spencer Schwartz
EVP & CFO |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 15.32% |
$265,200
$53.04 p/Share
|
Jan 29
2021 |
TWO
|
Rebecca B Sandberg
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 8,697 Reduced 4.12% |
$52,356
$6.02 p/Share
|
Jan 29
2021 |
TWO
|
Mary Kathryn Riskey
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 5,957 Reduced 5.31% |
$35,861
$6.02 p/Share
|
Jan 29
2021 |
TWO
|
Matthew Koeppen |
SELL
Open market or private sale
|
Direct | 2,583 Reduced 1.52% |
$15,575
$6.03 p/Share
|
Jan 29
2021 |
TWO
|
William Ross Greenberg
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 4,209 Reduced 2.25% |
$25,380
$6.03 p/Share
|
Jan 29
2021 |
PHR
|
Amy Beth Van Duyn
SVP, Human Resources |
SELL
Open market or private sale
|
Direct | 21,829 Reduced 29.56% |
$1,446,826
$66.28 p/Share
|
Jan 29
2021 |
ARQT
|
Bhaskar Chaudhuri
Director |
SELL
Open market or private sale
|
Direct | 51 Reduced 0.01% |
$1,402
$27.5 p/Share
|
Jan 29
2021 |
MORF
|
Omega Fund V, L.P.
Director |
SELL
Open market or private sale
|
Direct | 10,334 Reduced 0.37% |
$348,359
$33.71 p/Share
|
Jan 29
2021 |
CSTL
|
Derek J Maetzold
Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct | 14,375 Reduced 1.71% |
$968,156
$67.35 p/Share
|
Jan 29
2021 |
RMNI
|
Daniel B. Winslow
EVP, CLO & Corp. Sec. |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 34.06% |
$70,200
$7.02 p/Share
|
Jan 29
2021 |
BGFV
|
Van B Honeycutt
Director |
SELL
Open market or private sale
|
Indirect | 38,900 Reduced 31.4% |
$546,934
$14.06 p/Share
|
Jan 29
2021 |
VRA
|
P. Michael Miller |
SELL
Open market or private sale
|
Indirect | 53,998 Reduced 2.75% |
$458,983
$8.5 p/Share
|
Jan 29
2021 |
VRA
|
Patricia R. Miller |
SELL
Open market or private sale
|
Indirect | 53,998 Reduced 2.75% |
$458,983
$8.5 p/Share
|
Jan 29
2021 |
DTIL
|
Derek Jantz
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 6,444 Reduced 0.16% |
$78,939
$12.25 p/Share
|
Jan 29
2021 |
LOV
|
Canaan Viii LP
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 0.28% |
$54,300
$5.43 p/Share
|
Jan 29
2021 |
GNLN
|
Adam Schoenfeld
Director |
SELL
Open market or private sale
|
Direct | 35,000 Reduced 66.46% |
$157,850
$4.51 p/Share
|
Jan 29
2021 |
WAVD
|
Sandor Rosenberg
Director |
SELL
Open market or private sale
|
Direct | 1,200,000 Reduced 65.03% |
$684,000
$0.57 p/Share
|
Jan 29
2021 |
ATAO
|
Erop Capital LLC |
SELL
Open market or private sale
|
Direct | 575,182 Reduced 1.38% |
$115,036
$0.2 p/Share
|
Jan 29
2021 |
BKKT
|
Alpine Global Management, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 717 Reduced 0.03% |
$10,504
$14.65 p/Share
|
Jan 29
2021 |
SSNT
|
Jeffrey D Roth
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 2.22% |
$54,600
$5.46 p/Share
|
Jan 29
2021 |
AIRT
|
Raymond E Cabillot
Director |
BUY
Open market or private purchase
|
Indirect | 1,291 Added 0.33% |
$26,143
$20.25 p/Share
|
Jan 29
2021 |
AIRT
|
Nicholas John Swenson
CEO |
BUY
Open market or private purchase
|
Indirect | 1,292 Added 0.14% |
$26,163
$20.25 p/Share
|
Jan 29
2021 |
MBCN
|
Michael C Voinovich
Director |
BUY
Open market or private purchase
|
Indirect | 1,000 Added 19.86% |
$19,600
$19.6 p/Share
|
Jan 29
2021 |
TDY
|
Robert Mehrabian
Executive Chairman |
BUY
Open market or private purchase
|
Indirect | 10,000 Added 1.9% |
$3,674,700
$367.47 p/Share
|
Jan 29
2021 |
BANF
|
Joe Goyne
Director |
BUY
Open market or private purchase
|
Direct | 600 Added 11.54% |
$34,800
$58.0 p/Share
|
Jan 29
2021 |
NFBK
|
David Fasanella
EVP |
BUY
Open market or private purchase
|
Direct | 1,750 Added 6.61% |
$22,050
$12.6 p/Share
|
Jan 29
2021 |
GNTY
|
James S. Bunch |
BUY
Open market or private purchase
|
Direct | 2,000 Added 1.71% |
$67,640
$33.82 p/Share
|
Jan 29
2021 |
RMT
|
Christopher D Clark
President |
BUY
Open market or private purchase
|
Direct | 8,000 Added 20.27% |
$86,240
$10.78 p/Share
|
Jan 29
2021 |
CHMG
|
David M Buicko
Director |
BUY
Open market or private purchase
|
Direct | 107 Added 2.42% |
$3,599
$33.64 p/Share
|
Jan 29
2021 |
MBCN
|
James R Heslop Ii
EVP/Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect | 500 Added 34.82% |
$9,835
$19.67 p/Share
|
Jan 29
2021 |